Deng Q - Search Results

1

Exosomes derived from M2 type tumor-associated macrophages promote osimertinib resistance in non-small cell lung cancer through MSTRG.292666.16-miR-6836-5p-MAPK8IP3 axis.

Wan X, Xie B, Sun H, Gu W, Wang C, Deng Q, Zhou S. Wan X, et al. Among authors: deng q. Cancer Cell Int. 2022 Feb 15;22(1):83. doi: 10.1186/s12935-022-02509-x. Cancer Cell Int. 2022. PMID: 35168607 Free PMC article.

2

Predictive effects of ERCC1 and XRCC3 SNP on efficacy of platinum-based chemotherapy in advanced NSCLC patients.

Zhou C, Ren S, Zhou S, Zhang L, Su C, Zhang Z, Deng Q, Zhang J. Zhou C, et al. Among authors: deng q. Jpn J Clin Oncol. 2010 Oct;40(10):954-60. doi: 10.1093/jjco/hyq071. Epub 2010 May 12. Jpn J Clin Oncol. 2010. PMID: 20462983

3

[Relationship between ID1 and EGFR-TKI Resistance  in Non-small Cell Lung Cancer].

Bao Y, Zhao Y, Chen B, Luo J, Deng Q, Sun H, Xie B, Zhou S. Bao Y, et al. Among authors: deng q. Zhongguo Fei Ai Za Zhi. 2016 Dec 20;19(12):864-870. doi: 10.3779/j.issn.1009-3419.2016.12.10. Zhongguo Fei Ai Za Zhi. 2016. PMID: 27978873 Free PMC article. Chinese.

4

SPOP promotes SIRT2 degradation and suppresses non-small cell lung cancer cell growth.

Luo J, Bao YC, Ji XX, Chen B, Deng QF, Zhou SW. Luo J, et al. Biochem Biophys Res Commun. 2017 Feb 5;483(2):880-884. doi: 10.1016/j.bbrc.2017.01.027. Epub 2017 Jan 7. Biochem Biophys Res Commun. 2017. PMID: 28073696

5

Liu C, Zhang YH, Deng Q, Li Y, Huang T, Zhou S, Cai YD. Liu C, et al. Among authors: deng q. Biomed Res Int. 2017;2017:3859582. doi: 10.1155/2017/3859582. Epub 2017 Feb 8. Biomed Res Int. 2017. PMID: 28280730 Free PMC article.

6

Corrigendum to "SPOP promotes SIRT2 degradation and suppresses non-small cell lung cancer cell growth" [Biochem. Biophys. Res. Commun. 483 (2017) 880-884].

Luo J, Bao YC, Ji XX, Chen B, Deng QF, Zhou SW. Luo J, et al. Biochem Biophys Res Commun. 2017 Apr 22;486(1):57. doi: 10.1016/j.bbrc.2017.02.122. Epub 2017 Mar 11. Biochem Biophys Res Commun. 2017. PMID: 28292429 No abstract available.

7

Competitive evolution of NSCLC tumor clones and the drug resistance mechanism of first-generation EGFR-TKIs in Chinese NSCLC patients.

Deng Q, Xie B, Wu L, Ji X, Li C, Feng L, Fang Q, Bao Y, Li J, Jin S, Ding C, Li Y, Zhou S. Deng Q, et al. Heliyon. 2018 Dec 19;4(12):e01031. doi: 10.1016/j.heliyon.2018.e01031. eCollection 2018 Dec. Heliyon. 2018. PMID: 30603682 Free PMC article.

8

Predictive value of unmethylated RASSF1A on disease progression in non-small cell lung cancer patients receiving pemetrexed-based chemotherapy.

Deng Q, Su B, Ji X, Fang Q, Zhou S, Zhou C. Deng Q, et al. Cancer Biomark. 2020;27(3):313-323. doi: 10.3233/CBM-190258. Cancer Biomark. 2020. PMID: 31839603

9

Detection of plasma EGFR mutations for personalized treatment of lung cancer patients without pathologic diagnosis.

Deng Q, Fang Q, Sun H, Singh AP, Alexander M, Li S, Cheng H, Zhou S. Deng Q, et al. Cancer Med. 2020 Mar;9(6):2085-2095. doi: 10.1002/cam4.2869. Epub 2020 Jan 28. Cancer Med. 2020. PMID: 31991049 Free PMC article.

10

A novel virtual barcode strategy for accurate panel-wide variant calling in circulating tumor DNA.

Wu L, Deng Q, Xu Z, Zhou S, Li C, Li YX. Wu L, et al. Among authors: deng q. BMC Bioinformatics. 2020 Apr 3;21(1):127. doi: 10.1186/s12859-020-3412-2. BMC Bioinformatics. 2020. PMID: 32245364 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,288 results

Search Page

Filters